ARTICLE | Company News
Progenitor, Valentis deal
May 23, 2005 7:00 AM UTC
VLTS received rights from Progenitor to an antibody against Del-1 and related IP. In 1999, VLTS received rights to Progenitor's Del-1 gene and protein (see BioCentury, May 3, 1999). Del-1 is an extrac...